The amplification of YAP is associated with poor survival in patients with head and neck cancers and high-grade OSCC, suggesting inhibition of YAP or its downregulation could improve the prognosis for some patients with oral cancer [93,94]. The gene discussed is YAP1; the disease is lip and oral cavity carcinoma.